Salmonella Protein AvrA Activates the STAT3 Signaling Pathway in Colon Cancer

Neoplasia (United States)

Volumn 18, Issue 5, 2016, Pages 307-316

  Lu, Rong ^a,g   Wu, Shaoping ^a   Zhang, Yong guo ^a,g   Xia, Yinglin ^b   Zhou, Zhongren ^c   Kato, Ikuko ^d   Dong, Hui ^e   Bissonnette, Marc ^f   Sun, Jun ^a,g  

^a RUSH UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e THIRD MILITARY MEDICAL UNIVERSITY   (China)

^f UNIVERSITY OF CHICAGO   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BACTERIAL PROTEIN; BETA CATENIN; COMPLEMENTARY DNA; CYCLINE; CYTOKINE; DEXTRAN SULFATE; INTERLEUKIN 6; RNA; SALMONELLA PROTEIN AVRA; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CANCER CELL; CELL PROLIFERATION; CHRONIC INFLAMMATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL DISEASE; GENE EXPRESSION; HISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLOSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT; ANIMAL; BIOLOGICAL MODEL; CHRONIC DISEASE; COLONIC NEOPLASMS; COMPLICATION; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SALMONELLA; TUMOR CELL LINE;

ANIMALS; BACTERIAL PROTEINS; BIOMARKERS; CELL LINE, TUMOR; CELL PROLIFERATION; CHRONIC DISEASE; COLONIC NEOPLASMS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MODELS, BIOLOGICAL; SALMONELLA; SALMONELLA INFECTIONS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 85011564318     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2016.04.001     Document Type: Article

References (43)

1. Coussens, LM, Werb, Z, Inflammation and cancer. Nature 420 (2002), 860–867.
2. Mantovani, A, Cancer: inflaming metastasis. Nature 457 (2009), 36–37.
3. Grivennikov, SI, Wang, K, Mucida, D, Stewart, CA, Schnabl, B, Jauch, D, Taniguchi, K, Yu, GY, Osterreicher, CH, Hung, KE, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17–mediated tumour growth. Nature 491 (2012), 254–258.
4. Wu, S, Rhee, KJ, Albesiano, E, Rabizadeh, S, Wu, X, Yen, HR, Huso, DL, Brancati, FL, Wick, E, McAllister, F, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15 (2009), 1016–1022.
5. Arthur, JC, Perez-Chanona, E, Muhlbauer, M, Tomkovich, S, Uronis, JM, Fan, TJ, Campbell, BJ, Abujamel, T, Dogan, B, Rogers, AB, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338 (2012), 120–123.
6. Song, M, Wu, K, Ogino, S, Fuchs, CS, Giovannucci, EL, Chan, AT, A prospective study of plasma inflammatory markers and risk of colorectal cancer in men. Br J Cancer 108 (2013), 1891–1898.
7. Gradel, KO, Nielsen, HL, Schonheyder, HC, Ejlertsen, T, Kristensen, B, Nielsen, H, Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 137 (2009), 495–501.
8. Kumar, S, Infection as a risk factor for gallbladder cancer. J Surg Oncol 93 (2006), 633–639.
9. Kato, I, Boleij, A, Kortman, GA, Roelofs, R, Djuric, Z, Severson, RK, Tjalsma, H, Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk. Nutr Cancer 65 (2013), 169–177.
10. Arrach, N, Zhao, M, Porwollik, S, Hoffman, RM, McClelland, M, Salmonella promoters preferentially activated inside tumors. Cancer Res 68 (2008), 4827–4832.
11. Zhao, M, Yang, M, Li, XM, Jiang, P, Baranov, E, Li, S, Xu, M, Penman, S, Hoffman, RM, Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A 102 (2005), 755–760.
12. Collier-Hyams, LS, Zeng, H, Sun, J, Tomlinson, AD, Bao, ZQ, Chen, H, Madara, JL, Orth, K, Neish, AS, Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol 169 (2002), 2846–2850.
13. Du, F, Galan, JE, Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog, 5, 2009, e1000595.
14. Hardt, WD, Galan, JE, A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. Proc Natl Acad Sci U S A 94 (1997), 9887–9892.
15. Liao, AP, Petrof, EO, Kuppireddi, S, Zhao, Y, Xia, Y, Claud, EC, Sun, J, Salmonella type III effector AvrA stabilizes cell tight junctions to inhibit inflammation in intestinal epithelial cells. PLoS One, 3, 2008, e2369.
16. Sun, J, Hobert, ME, Rao, AS, Neish, AS, Madara, JL, Bacterial activation of beta-catenin signaling in human epithelia. Am J Physiol Gastrointest Liver Physiol 287 (2004), G220–G227.
17. Ye, Z, Petrof, EO, Boone, D, Claud, EC, Sun, J, Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol 171 (2007), 882–892.
18. Liu, X, Lu, R, Wu, S, Sun, J, Salmonella regulation of intestinal stem cells through the Wnt/beta-catenin pathway. FEBS Lett 584 (2010), 911–916.
19. Lu, R, Wu, S, Zhang, Y, Xia, Y, Liu, X, Zheng, Y, Chen, H, Schaefer, KL, Zhou, Z, Bissonnette, M, et al. Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway oncogenesis. 2014.
20. Grivennikov, SI, Greten, FR, Karin, M, Immunity, inflammation, and cancer. Cell 140 (2010), 883–899.
21. Rostom, A, Dube, C, Lewin, G, Tsertsvadze, A, Barrowman, N, Code, C, Sampson, M, Moher, D, Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146 (2007), 376–389.
22. Dube, C, Rostom, A, Lewin, G, Tsertsvadze, A, Barrowman, N, Code, C, Sampson, M, Moher, D, The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146 (2007), 365–375.
23. Plevy, S, A STAT need for human immunologic studies to understand inflammatory bowel disease. Am J Gastroenterol 100 (2005), 73–74.
24. Grivennikov, S, Karin, E, Terzic, J, Mucida, D, Yu, GY, Vallabhapurapu, S, Scheller, J, Rose-John, S, Cheroutre, H, Eckmann, L, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15 (2009), 103–113.
25. Lu, R, Wu, S, Liu, X, Xia, Y, Zhang, YG, Sun, J, Chronic effects of a Salmonella type III secretion effector protein AvrA in vivo. PLoS One, 5, 2010, e10505.
26. Sun, J, Hobert, ME, Duan, Y, Rao, AS, He, TC, Chang, EB, Madara, JL, Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 289 (2005), G129–G137.
27. Duan, Y, Liao, AP, Kuppireddi, S, Ye, Z, Ciancio, MJ, Sun, J, beta-Catenin activity negatively regulates bacteria-induced inflammation. Lab Invest 87 (2007), 613–624.
28. Miller, SI, Mekalanos, JJ, Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J Bacteriol 172 (1990), 2485–2490.
29. Jarnicki, A, Putoczki, T, Ernst, M, Stat3: linking inflammation to epithelial cancer — more than a “gut” feeling?. Cell Div, 5, 2010, 14.
30. Kimura, A, Kishimoto, T, IL-6: regulator of Treg/Th17 balance. Eur J Immunol 40 (2010), 1830–1835.
31. Ho, GY, Wang, T, Gunter, MJ, Strickler, HD, Cushman, M, Kaplan, RC, Wassertheil-Smoller, S, Xue, X, Rajpathak, SN, Chlebowski, RT, et al. Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res 72 (2012), 3029–3037.
32. Grivennikov, SI, Karin, M, Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21 (2010), 11–19.
33. Lee, SH, Hu, LL, Gonzalez-Navajas, J, Seo, GS, Shen, C, Brick, J, Herdman, S, Varki, N, Corr, M, Lee, J, et al. ERK activation drives intestinal tumorigenesis in Apc(min/+) mice. Nat Med 16 (2010), 665–670.
34. Hao, J, Li, TG, Qi, X, Zhao, DF, Zhao, GQ, WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev Biol 290 (2006), 81–91.
35. Yan, S, Zhou, C, Zhang, W, Zhang, G, Zhao, X, Yang, S, Wang, Y, Lu, N, Zhu, H, Xu, N, beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. Cancer Lett 271 (2008), 85–97.
36. Armanious, H, Gelebart, P, Mackey, J, Ma, Y, Lai, R, STAT3 upregulates the protein expression and transcriptional activity of beta-catenin in breast cancer. Int J Clin Exp Pathol 3 (2010), 654–664.
37. Greten, FR, Karin, M, The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer Lett 206 (2004), 193–199.
38. Dieleman, LA, Palmen, MJ, Akol, H, Bloemena, E, Pena, AS, Meuwissen, SG, Van Rees, EP, Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114 (1998), 385–391.
39. Sellon, RK, Tonkonogy, S, Schultz, M, Dieleman, LA, Grenther, W, Balish, E, Rennick, DM, Sartor, RB, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10–deficient mice. Infect Immun 66 (1998), 5224–5231.
40. Boivin, GP, Washington, K, Yang, K, Ward, JM, Pretlow, TP, Russell, R, Besselsen, DG, Godfrey, VL, Doetschman, T, Dove, WF, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124 (2003), 762–777.
41. Wu, S, Liao, AP, Xia, Y, Li, YC, Li, JD, Sartor, RB, Sun, J, Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol 177 (2010), 686–697.
42. Sun, J, Kong, J, Duan, Y, Szeto, FL, Liao, A, Madara, JL, Li, YC, Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 291 (2006), E315–E322.
43. Zeger, SL, Liang, KY, Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986), 121–130.